Wang G, Wang D, Xia L, Lian J, Zhang Q, Shen D
ACS Appl Mater Interfaces. 2025; 17(5):7478-7488.
PMID: 39871538
PMC: 11803545.
DOI: 10.1021/acsami.4c21028.
Qi L, Du Y, Huang Y, Kogiso M, Zhang H, Xiao S
Br J Cancer. 2024; 131(2):258-270.
PMID: 38834745
PMC: 11263392.
DOI: 10.1038/s41416-024-02724-5.
Angom R, Nakka N, Bhattacharya S
Brain Sci. 2023; 13(11).
PMID: 38002496
PMC: 10669378.
DOI: 10.3390/brainsci13111536.
Tallman M, Zalenski A, Stabl I, Schrock M, Kollin L, de Jong E
Cancers (Basel). 2023; 15(12).
PMID: 37370783
PMC: 10296095.
DOI: 10.3390/cancers15123173.
Kilmister E, Koh S, Weth F, Gray C, Tan S
Biomedicines. 2022; 10(11).
PMID: 36428556
PMC: 9687343.
DOI: 10.3390/biomedicines10112988.
Lipid metabolism of cancer stem cells.
Liu H, Zhang Z, Song L, Gao J, Liu Y
Oncol Lett. 2022; 23(4):119.
PMID: 35261633
PMC: 8855159.
DOI: 10.3892/ol.2022.13239.
Carbon-Ion Beam Irradiation and the miR-200c Mimic Effectively Eradicate Pancreatic Cancer Stem Cells Under in vitro and in vivo Conditions.
Sai S, Kim E, Koom W, Vares G, Suzuki M, Yamada S
Onco Targets Ther. 2021; 14:4749-4760.
PMID: 34556996
PMC: 8453446.
DOI: 10.2147/OTT.S311567.
Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas.
Cook K, Shen H, McKelvey K, Gee H, Hau E
Int J Mol Sci. 2021; 22(14).
PMID: 34298883
PMC: 8305417.
DOI: 10.3390/ijms22147265.
Superior Effect of the Combination of Carbon-Ion Beam Irradiation and 5-Fluorouracil on Colorectal Cancer Stem Cells in vitro and in vivo.
Koom W, Sai S, Suzuki M, Fujimori A, Yamada S, Tsujii H
Onco Targets Ther. 2020; 13:12625-12635.
PMID: 33335403
PMC: 7737548.
DOI: 10.2147/OTT.S276035.
mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
Nakano T, Warner K, Oklejas A, Zhang Z, Rodriguez-Ramirez C, Shuman A
J Dent Res. 2020; 100(4):377-386.
PMID: 33073679
PMC: 7989140.
DOI: 10.1177/0022034520965141.
Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.
Sai S, Kim E, Vares G, Suzuki M, Yu D, Horimoto Y
Am J Cancer Res. 2020; 10(8):2371-2386.
PMID: 32905515
PMC: 7471364.
Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas.
Shen H, Cook K, Gee H, Hau E
J Exp Clin Cancer Res. 2020; 39(1):129.
PMID: 32631383
PMC: 7339573.
DOI: 10.1186/s13046-020-01639-2.
Stem cells in cancer initiation and progression.
Bajaj J, Diaz E, Reya T
J Cell Biol. 2019; 219(1).
PMID: 31874116
PMC: 7039188.
DOI: 10.1083/jcb.201911053.
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.
Kielbassa K, Vegna S, Ramirez C, Akkari L
Front Immunol. 2019; 10:2215.
PMID: 31611871
PMC: 6773830.
DOI: 10.3389/fimmu.2019.02215.
Tannic acid attenuates the formation of cancer stem cells by inhibiting NF-κB-mediated phenotype transition of breast cancer cells.
Kim D, Choi H, Ryu E, Ko J, Shin H, Lee J
Am J Cancer Res. 2019; 9(8):1664-1681.
PMID: 31497349
PMC: 6726983.
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.
Koschorke A, Faraci S, Giani D, Chiodoni C, Iorio E, Canese R
Cell Oncol (Dordr). 2019; 42(6):815-828.
PMID: 31376137
DOI: 10.1007/s13402-019-00464-w.
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
Andrews A, Warner K, Rodriguez-Ramirez C, Pearson A, Nor F, Zhang Z
Clin Cancer Res. 2018; 25(5):1588-1600.
PMID: 30498096
PMC: 6397688.
DOI: 10.1158/1078-0432.CCR-17-2730.
Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth.
Duan C, Yang R, Yuan L, Engelbach J, Tsien C, Rich K
Int J Radiat Oncol Biol Phys. 2018; 103(1):190-194.
PMID: 30171879
PMC: 6849509.
DOI: 10.1016/j.ijrobp.2018.08.033.
The effects of extra high dose rate irradiation on glioma stem-like cells.
Hao J, Godley A, Shoemake J, Han Z, Magnelli A, Yu J
PLoS One. 2018; 13(8):e0202533.
PMID: 30118510
PMC: 6097670.
DOI: 10.1371/journal.pone.0202533.
ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.
Ronco C, Martin A, Demange L, Benhida R
Medchemcomm. 2018; 8(2):295-319.
PMID: 30108746
PMC: 6072143.
DOI: 10.1039/c6md00439c.